Analytical Study of Antipsychotic Use in Schizophrenia Patients
International Journal of Health and Pharmaceutical (IJHP) · 15.06.2026 · 6 (2) · 377-387
DOI: 10.51601/ijhp.v6i2.650 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health and Pharmaceutical (IJHP), online erschienen am 15.06.2026. Verfasst von Sinta Wahyuni und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Schizophrenia is a chronic mental disorder that affects thought processes, emotions, perceptions, and behavior. Antipsychotics are divided into first-generation (FGA) and second-generation (SGA) as the main therapy.
Objective
To analyze the profile of antipsychotic use in hospitalized schizophrenia patients, including type, dose, route, frequency, and combination patterns.
Methods
A retrospective observational study at Menur Mental Hospital Surabaya from July to September 2023 on 66 hospitalized schizophrenia patients. Data were analyzed descriptively.
Results
The use of SGAs was more dominant than FGAs. The most common SGAs were clozapine 25 mg and risperidone 3 mg oral. The most common FGAs were trifluoperazine 5 mg and chlorpromazine 100 mg oral. The most common combination pattern was risperidone + clozapine.
Conclusion
The pattern of antipsychotic use was dominated by the combination of risperidone and clozapine, reflecting the complexity of schizophrenia management that requires an individual approach.
Zitieren
APA
Wahyuni, S., Yulistiani, Zeth, I., & P, J. (2026). Analytical Study of Antipsychotic Use in Schizophrenia Patients. International Journal of Health and Pharmaceutical (IJHP), 6(2), 377-387. https://doi.org/10.51601/ijhp.v6i2.650
Vancouver
Wahyuni S, Yulistiani, Zeth I, P J. Analytical Study of Antipsychotic Use in Schizophrenia Patients. International Journal of Health and Pharmaceutical (IJHP). 2026;6(2):377-387. doi:10.51601/ijhp.v6i2.650
BibTeX
@article{Wahyuni2026,
author = {Wahyuni, Sinta and Yulistiani and Zeth, Indra and P, Josephine},
title = {Analytical Study of Antipsychotic Use in Schizophrenia Patients},
journal = {International Journal of Health and Pharmaceutical (IJHP)},
year = {2026},
volume = {6},
number = {2},
pages = {377--387},
doi = {10.51601/ijhp.v6i2.650}
}
EUVIMED